Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: A phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Alba A. Brandes, Alicia Tosoni, Umberto Basso, Michele Reni, Francesco Valduga, Silvio Monfardini, Pietro Amistà, Linda Nicolardi, Guido Sotti, Mario Ermani

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: A phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)'. Together they form a unique fingerprint.

Medicine & Life Sciences